← Leaderboards
Clara Curiel-Lewandrowski
University Of Arizona
$4,151,872
Attributed
$6,163,072
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,909,060 · 12
By mechanism
P01$12,343,663 · 9
UG3$2,194,389 · 2
T32$1,371,008 · 1
Top collaborators
- Gregory Charles Rogers5 shared
- David S Alberts3 shared
- Anne Elizabeth Cress3 shared
- Zigang Dong3 shared
- Steven P Stratton3 shared
- Jennifer S Carew2 shared
- Georg T Wondrak2 shared
- Sally E Dickinson1 shared
Most similar at University Of Arizona
Same institution · by research overlap
- David S Alberts$22,074,619
- Georg T Wondrak$5,087,049
- George Timothy Bowden$6,009,884
- Dongkyun Kang$3,478,279
- Steven P Stratton$2,491,979
Others in their field
Top investigators on “Skin Carcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$89,819,252
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$23,354,043
- John James McNeil · Hennepin Healthcare Research Institute$22,201,424
- Richard H Grimm · University Of Minnesota Twin Cities$17,709,591
- Allan Balmain · University Of California San Francisco$16,932,359
- Michele Follen · University Of Texas Md Anderson Can Ctr$16,682,265
Research focus
Skin CarcinomaMalignant NeoplasmsPreventionSkin CancerSkinProgramsNovel TherapeuticsIncidencePathway InteractionsSafetySkin CarcinogenesisMorbidity - Disease RateSkin Squamous Cell CarcinomaSkin Cancer PreventionActinic KeratosisSignal TransductionLightHealth Care CostsBiological MarkersMultidisciplinarySignal PathwayPre-ClinicalChemopreventionCost
Grant awards (32)
Image Deeper with Synthetic Waves: A Novel Non-Invasive Optical Approach for Skin Lesion Assessment at Multiple Scales$1,732,297
UG3 · FY2025 · DA
Investigating novel targets for topical immunoprevention of keratinocytic skin cancer$462,092
UG3 · FY2025 · CA
Integrative Cancer Scholars Training Grant$287,821
T32 · FY2024 · CA
Targeted Prevention for Non-Melanoma Skin Cancer$1,301,234
P01 · FY2023 · CA · contact PI
Integrative Cancer Scholars Training Grant$263,644
T32 · FY2023 · CA
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin$227,489
P01 · FY2023 · CA · contact PI
Core A: Administration$163,883
P01 · FY2023 · CA · contact PI
Targeted Prevention for Non-Melanoma Skin Cancer$1,359,369
P01 · FY2022 · CA · contact PI
Integrative Cancer Scholars Training Grant$274,603
T32 · FY2022 · CA
Core A: Administration$247,582
P01 · FY2022 · CA · contact PI
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin$234,461
P01 · FY2022 · CA · contact PI
Targeted Prevention for Non-Melanoma Skin Cancer$234,461
P01 · FY2022 · CA · contact PI
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin$224,173
P01 · FY2022 · CA · contact PI
Targeted Prevention for Non-Melanoma Skin Cancer$1,383,249
P01 · FY2021 · CA · contact PI
Integrative Cancer Scholars Training Grant$268,540
T32 · FY2021 · CA
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin$227,817
P01 · FY2021 · CA · contact PI
Core A: Administration$162,590
P01 · FY2021 · CA · contact PI
Core A: Administration$91,467
P01 · FY2021 · CA · contact PI
Core A: Administration$66,068
P01 · FY2021 · CA · contact PI
Targeted Prevention for Non-Melanoma Skin Cancer$66,068
P01 · FY2021 · CA · contact PI
Targeted Prevention for Non-Melanoma Skin Cancer$1,374,934
P01 · FY2020 · CA · contact PI
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin$276,641
P01 · FY2020 · CA · contact PI
Integrative Cancer Scholars Training Grant$276,400
T32 · FY2020 · CA
Core A: Administration$183,936
P01 · FY2020 · CA · contact PI
Core A: Administration$33,928
P01 · FY2020 · CA · contact PI
Targeted Prevention for Non-Melanoma Skin Cancer$33,928
P01 · FY2020 · CA · contact PI
Targeted Prevention for Non-Melanoma Skin Cancer$1,392,093
P01 · FY2019 · CA · contact PI
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin$273,704
P01 · FY2019 · CA · contact PI
Core A: Administration$183,936
P01 · FY2019 · CA · contact PI
Chemoprevention of Skin Cancer Program Project$1,312,638
P01 · FY2015 · CA
Chemoprevention of Skin Cancer Program Project$11,328
P01 · FY2015 · CA
Chemoprevention of Skin Cancer Program Project$1,276,686
P01 · FY2014 · CA